Physician profile
Craig A Silver
NPI 1295762458
$1,215.49
in general payments reported to CMS, 2019-2025
21 companies · $554 in 2025
The $554 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $87.39 · 2021: $84.47 · 2022: $29.46 · 2023: $105 · 2024: $140 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $180.64 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $158.48 | 2019-2021 | |
| Boston Scientific Corporation | $144.26 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $118.04 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $117.42 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $73.07 | 2025 | |
| Dexcom, INC. | $63.05 | 2024-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $53.19 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $45.76 | 2019-2025 | Wainua |
| Lilly USA, LLC | $33.99 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $32.51 | 2021-2025 | Rybelsus, Ozempic |
| 180 Medical, INC. | $29.46 | 2022 | |
| Impulse Dynamics (USA) INC. | $22.77 | 2025 | Optimizer |
| Abbvie INC. | $20.91 | 2025 | |
| Hologic Sales and Service, LLC | $20.39 | 2024 | Thinprep 2000 Processor, Aptima |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $19.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.38 | 2025 | |
| Esperion Therapeutics, INC. | $17.72 | 2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $16.86 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.29 | 2020 | |
| Medicomp INC | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.